TG Therapeutics (TGTX) Reports Q4 Loss of $0.37/Share

TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.37), versus ($0.48) reported last year. Revenue for the quarter came in at $38.1 million, versus $38.1 million reported last year.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy
• RBC Capital Downgrades Hermes International (RMS:FP) (HESAY) to Sector Perform